Navigation Links
US FDA Official Rick Friedman to Present Plenary at ISPE Aseptic Education Intensive

Tampa, Fla. USA (PRWEB) February 21, 2013

ISPE announced today that Rick Friedman, Associate Director, OMPQ, US FDA, will be the plenary speaker at the association’s two-day education intensive on aseptic processes for the pharmaceutical industry. The event will take place on 4 – 5 March 2013 in Baltimore, Maryland USA.

“ISPE conferences are an important neutral meeting-ground for regulators and pharmaceutical professionals from around the world to discuss technical challenges,” said Nancy Berg, ISPE President and CEO. “By bringing together top industry experts and high-level regulators like Mr. Friedman, ISPE will facilitate collaboration and sharing of best practices that is essential to the production of a safe global drug supply.”

The two-day event will present the latest in aseptic processes. Discussions will focus on disposables, barrier isolation and containment technologies, cleaning and sterilization. Regulators and pharma experts will present state-of-the-art developments in sterile process improvements, risk mitigation, cost-effective processing and innovative applications.

In addition to Friedman, notable speakers at this conference include:

  • Charlotte Enghave Fruergaard, PhD, Director of Technology, NNE Pharmaplan, 2012-2013 Chair, ISPE International Board of Directors, Aseptic Conference Honorary Chair
  • Destry Sillivan, Senior Regulatory Review Officer, US FDA
  • Robert Sausville, Director, Division of Case Management (DCM) Office of Compliance and Biologics Quality, at FDA’s Center for Biologics Evaluation and Research, US FDA
  • Dave Doleski, Acting Director, Division of Good Manufacturing Practice Assessment, OMPQ, OC, CDER, US FDA

Pharma industry executives leading this event and serving as moderators include:

  • Ryan Hawkins, Vice President Operations, Cook Pharmica, USA
  • Jack Lysfjord, Principal Consultant, Lysfjord Consulting LLC, USA
  • Joerg Zimmermann, Director Process Development and Implementation, Vetter Pharma Fertigung GmbH & Co. KG, Germany
  • Rebecca Brewer, Director, Validation and GMP Compliance, Dober Group, USA
  • Gordon Leichter, PhD, Regional Sales Manager, Belimed, Inc., USA

More information on the 2013 ISPE Aseptic Intensive, including complete education details and registration information, is available at

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit for more information.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Tianli-Xiduhei(TM) Black Pork Meat Makes Official Debut in Beijing Food Stores
2. How to Check for Bed Bugs in Houses, Hotels and Offices - Releases It's Official Easy-to-Follow Guide
3. Officials Find Bed Bugs in Wall Street Journal; Spray For Bed Bugs Offers Advice How to Safely Counter Possible Bed Bug Comeback
4. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
5. The BBVA Foundation Frontiers of Knowledge Award goes to Coleman and Friedman, discoverers of the appetite hormone
6. Life Technologies to Present at Barclays Global Healthcare Conference
7. AbbVie to Present at Cowen and Company 33rd Annual Health Care Conference
8. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
9. PDL BioPharma to Present at Two Upcoming Investor Conferences
10. Sigma-Aldrich Corporation Declares Increased Quarterly Dividend; Announces Live Webcasts Of Presentations At Two Upcoming Conferences
11. Patheon to Present at Informex USA
Post Your Comments:
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):